Review decision
NICE technology appraisal guidance No.20 on the use of riluzole for motor neurone disease
Following consultation, the majority of comments received have led to the agreement that the existing guidance on riluzole for motor neurone disease becomes static guidance.
The list of static technology appraisal guidance will be updated accordingly.
3 April 2006
This page was last updated: 30 March 2010